Allogeneic bone-marrow–derived mesenchymal stem cells may prove to be an effective treatment for type 2 diabetes, a new pilot study suggests.
The researchers from University of British Columbia, Canada, have found a new quicker way to develop insulin producing beta cells from stem cells.
An Egyptian team of researchers in their attempt to develop stem cell treatment for diabetes produced insulin producing cells from stem cells in diabetic mice.
The researchers were working with mice cells, but they hope that the method may be developed in the future to give cure for diabetes to the humans.All news
Stem Cell Therapy Center EmCell offers a new, advanced, patented fetal stem cell transplant-based method for diabetes mellitus that has proved effective in treating for both types 1 and 2 diabetes, and in preventing diabetes-related complications, which usually affect the eyes, arteries, kidneys and so on.
In combination with traditional treatment of type 1 diabetes, fetal stem cells (FSC) can help:
In type 2 treatment, fetal stem cells can help:
Since 1994, EmCell has treated more than 750 diabetic patients 65% of whom reported a number of improvements:
If recommendations are followed and the patient’s lifestyle is healthy, a gradual decrease in hypoglycemic medication doses is also possible.
Diabetes Treatment for Children
Fetal stem cell therapy is one of the most effective treatments for type 1 diabetes mellitus in children and the only one that can slow down or temporarily terminate autoimmune aggression against pancreatic beta cells. If treatment is started within 6-8 weeks after onset, it is possible to prolong “honeymoon” period, sometimes for a long period of time.
In children, fetal stem cell therapy results in:
Stem cell therapy is most effective at the early stages of diabetes. The main criterion for positive effects with diabetes is long-term management of the disease and the inhibition or prevention of complications.
Typically, diabetes treatment at Cell Therapy Center EmCell lasts 2 days.
Fetal Stem Cell Transplantation in Metabolic Syndrome. Poster session.
English, jpg, 2.3 Mb
Fetal Stem Cells in Diabetic Nephropathy. Poster session.
English, jpg, 800 kb
Fetal Stem Cell Transplantation in Diabetes Mellitus. Poster session.
English, pdf, 1.6 Mb
Patient M.A., 49. Advanced subcompensated diabetes mellitus, type 2
Patient Z., 57. Type 2 moderate subcompensated diabetes mellitus
Patient A., 54. Advanced decompensated type 2 diabetes mellitus. Ischemic heart disease
Patient J. Sch.-J., 49. Type I diabetes and diabetic neuropathy